Sweden: Jenny Sundqvist named as new CEO of InDex Pharmaceuticals

InDex Pharmaceuticals, a pharmaceutical development company focusing on immunological diseases, has named Jenny Sundqvist as its new CEO. She takes on the role from January 1, 2023. Sundqvist has broad experience from leading positions within the pharmaceutical industry, most recently as chief commercial officer at Isofol Medical. Johan Giléus, who has been acting CEO since…

You must be a HMI Subscriber to view this content.

Subscribe Now »